Magnus Financial Group »

Generate Biomedicines Ord shares owned by Magnus Financial Group

Quarter-by-quarter ownership of Generate Biomedicines Ord (GENB) shares owned by Magnus Financial Group from 13F filings

Historical chart of Magnus Financial Group investment in Generate Biomedicines Ord

Tip: Access up to 7 years of quarterly data

All positions including Generate Biomedicines Ord held by Magnus Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Generate Biomedicines Ord by Magnus Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $263k 16k 16.87

More positions owned by Magnus Financial Group

Spdr Series Trust St Str P500val (SPYV)
Vanguard Index Fds Growth Etf (VUG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Scp Etf (IJR)
Apple (AAPL)
Tortoise Capital Series Trus North Amrcn Pipe (TPYP)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
J P Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Ishares Tr U.s. Finls Etf (IYF)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr U.s. Real Es Etf (IYR)
JPMorgan Chase & Co. (JPM)

View all positions for Magnus Financial Group

Top funds holding Generate Biomedicines Ord

Flagship Ventures Management
FMR
Capital World Investors
Braidwell
Arch Venture Corp
HarbourVest Partners
Baker Bros. Advisors
Harvard Management Company
Nvidia Corp
Siren
Davern Capital Partners
Alyeska Investment Group
ARK Investment Management
Millennium Management
UBS Group

View all funds holding Generate Biomedicines Ord